Preliminary experiments point out conolidine could inhibit particular ion channels, lowering neuronal excitability and restricting discomfort alerts. This system is particularly relevant in neuropathic soreness, wherever abnormal signaling brings about persistent pain. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to discomfort perception. https://edwardq471byu3.topbloghub.com/profile